838 related articles for article (PubMed ID: 12446577)
1. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis.
Fekete C; Kelly J; Mihály E; Sarkar S; Rand WM; Légrádi G; Emerson CH; Lechan RM
Endocrinology; 2001 Jun; 142(6):2606-13. PubMed ID: 11356711
[TBL] [Abstract][Full Text] [Related]
3. Agouti-related protein (AGRP) has a central inhibitory action on the hypothalamic-pituitary-thyroid (HPT) axis; comparisons between the effect of AGRP and neuropeptide Y on energy homeostasis and the HPT axis.
Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Lechan RM
Endocrinology; 2002 Oct; 143(10):3846-53. PubMed ID: 12239096
[TBL] [Abstract][Full Text] [Related]
4. Arcuate nucleus ablation prevents fasting-induced suppression of ProTRH mRNA in the hypothalamic paraventricular nucleus.
Legradi G; Emerson CH; Ahima RS; Rand WM; Flier JS; Lechan RM
Neuroendocrinology; 1998 Aug; 68(2):89-97. PubMed ID: 9705575
[TBL] [Abstract][Full Text] [Related]
5. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus.
Légrádi G; Emerson CH; Ahima RS; Flier JS; Lechan RM
Endocrinology; 1997 Jun; 138(6):2569-76. PubMed ID: 9165050
[TBL] [Abstract][Full Text] [Related]
6. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
Henry M; Ghibaudi L; Gao J; Hwa JJ
Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
[TBL] [Abstract][Full Text] [Related]
7. Effect of Agouti-related protein in regulation of the hypothalamic-pituitary-thyroid axis in the melanocortin 4 receptor knockout mouse.
Fekete C; Marks DL; Sarkar S; Emerson CH; Rand WM; Cone RD; Lechan RM
Endocrinology; 2004 Nov; 145(11):4816-21. PubMed ID: 15256492
[TBL] [Abstract][Full Text] [Related]
8. Central NPY-Y5 receptors activation plays a major role in fasting-induced pituitary-thyroid axis suppression in adult rat.
Costa-e-Sousa RH; Souza LL; Calviño C; Cabanelas A; Almeida NA; Oliveira KJ; Pazos-Moura CC
Regul Pept; 2011 Nov; 171(1-3):43-7. PubMed ID: 21771616
[TBL] [Abstract][Full Text] [Related]
9. Central administration of neuropeptide Y reduces alpha-melanocyte-stimulating hormone-induced cyclic adenosine 5'-monophosphate response element binding protein (CREB) phosphorylation in pro-thyrotropin-releasing hormone neurons and increases CREB phosphorylation in corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus.
Sarkar S; Lechan RM
Endocrinology; 2003 Jan; 144(1):281-91. PubMed ID: 12488356
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
11. Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity.
Dimitrov EL; DeJoseph MR; Brownfield MS; Urban JH
Endocrinology; 2007 Aug; 148(8):3666-73. PubMed ID: 17463058
[TBL] [Abstract][Full Text] [Related]
12. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
Dumont Y; Gaudreau P; Mazzuferi M; Langlois D; Chabot JG; Fournier A; Simonato M; Quirion R
Br J Pharmacol; 2005 Dec; 146(8):1069-81. PubMed ID: 16231000
[TBL] [Abstract][Full Text] [Related]
13. Prepro-orexin and feeding-related peptide receptor expression in dehydration-induced anorexia.
García-Luna C; Amaya MI; Alvarez-Salas E; de Gortari P
Regul Pept; 2010 Jan; 159(1-3):54-60. PubMed ID: 19800927
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y induced feeding in the rat is mediated by a novel receptor.
O'Shea D; Morgan DG; Meeran K; Edwards CM; Turton MD; Choi SJ; Heath MM; Gunn I; Taylor GM; Howard JK; Bloom CI; Small CJ; Haddo O; Ma JJ; Callinan W; Smith DM; Ghatei MA; Bloom SR
Endocrinology; 1997 Jan; 138(1):196-202. PubMed ID: 8977404
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism.
Billington CJ; Briggs JE; Harker S; Grace M; Levine AS
Am J Physiol; 1994 Jun; 266(6 Pt 2):R1765-70. PubMed ID: 8024026
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of central leptin, insulin, or glucose administration during fasting on the hypothalamic-pituitary-thyroid axis and feeding-related neurons in the arcuate nucleus.
Fekete C; Singru PS; Sanchez E; Sarkar S; Christoffolete MA; Riberio RS; Rand WM; Emerson CH; Bianco AC; Lechan RM
Endocrinology; 2006 Jan; 147(1):520-9. PubMed ID: 16210367
[TBL] [Abstract][Full Text] [Related]
17. Chronic neuropeptide Y Y5 receptor stimulation suppresses reproduction in virgin female and lactating rats.
Toufexis DJ; Kyriazis D; Woodside B
J Neuroendocrinol; 2002 Jun; 14(6):492-7. PubMed ID: 12047724
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
19. Y1 receptor activation is involved in the effect of exogenous neuropeptide Y on pup growth and the early termination of lactational diestrus in the postpartum rat.
Toufexis DJ; Yorozu S; Woodside B
J Neuroendocrinol; 2002 May; 14(5):354-60. PubMed ID: 12000540
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system.
Fu LY; Acuna-Goycolea C; van den Pol AN
J Neurosci; 2004 Oct; 24(40):8741-51. PubMed ID: 15470140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
